Mitochondrial DNA Depletion in Respiratory Chain–Deficient Parkinson Disease Neurons

To determine the extent of respiratory chain abnormalities and investigate the contribution of mtDNA to the loss of respiratory chain complexes (CI–IV) in the substantia nigra (SN) of idiopathic Parkinson disease (IPD) patients at the single‐neuron level.

• Publication year

  2016

• Venue

  Annals of Neurology

• Publication date

  2016-01-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ana.24571PMID 26605748PMCID 4819690
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetics of Parkinson's disease

  2018cited by this paper
• Respiratory chain protein turnover rates in mice are highly heterogeneous but strikingly conserved across tissues, ages, and treatments

  2015cited by this paper
• Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease

  2015cited by this paper
• Triplex real-time PCR–an improved method to detect a wide spectrum of mitochondrial DNA deletions in single cells

  2015cited by this paper
• Molecular Pathogenesis of Polymerase Gamma–Related Neurodegeneration

  2014cited by this paper
• In D-loop: 40 years of mitochondrial 7S DNA.

  2014cited by this paper
• Axial mitochondrial myopathy in a patient with rapidly progressive adult-onset scoliosis

  2014cited by this paper
• Quantitative quadruple-label immunofluorescence of mitochondrial and cytoplasmic proteins in single neurons from human midbrain tissue

  2014influential reference
• Mitochondrial DNA Rearrangements in Health and Disease—A Comprehensive Study

  2014cited by this paper
• Distinct structural features of TFAM drive mitochondrial DNA packaging versus transcriptional activation

  2014cited by this paper
• The Impact of Pathogenic Mitochondrial DNA Mutations on Substantia Nigra Neurons

  2013cited by this paper
• Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number.

  2012influential reference
• Parkinson's disease and parkinsonism: neuropathology.

  2012cited by this paper
• Relationship between mitochondria and α-synuclein: a study of single substantia nigra neurons.

  2012cited by this paper
• Mitochondrial pathology in Parkinson's disease.

  2011cited by this paper
• The relationship between mitochondria and α-synuclein-A study of single substantia nigra neurons

  2011cited by this paper
• Structure of human mitochondrial RNA polymerase

  2011cited by this paper
• TFAM forces mtDNA to make a U-turn

  2011cited by this paper
• Genetics of Parkinson's Disease

  2011cited by this paper
• MitoPark mice mirror the slow progression of key symptoms and L‐DOPA response in Parkinson's disease

  2010cited by this paper
• Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients.

  2010cited by this paper
• Parkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in heteroplasmic mtDNA mutation abundance

  2009cited by this paper
• Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis.

  2009cited by this paper
• Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications.

  2009cited by this paper
• Resistance training in patients with single, large-scale deletions of mitochondrial DNA.

  2008cited by this paper
• Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons

  2007cited by this paper
• A multiplex real-time PCR method to detect and quantify mitochondrial DNA deletions in individual cells.

  2007cited by this paper
• Relative abundance of the human mitochondrial transcription system and distinct roles for h-mtTFB1 and h-mtTFB2 in mitochondrial biogenesis and gene expression

  2007cited by this paper
• High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

  2006influential reference
• Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons

  2006cited by this paper
• Control of Mitochondrial Transcription Specificity Factors (TFB1M and TFB2M) by Nuclear Respiratory Factors (NRF-1 and NRF-2) and PGC-1 Family Coactivators

  2005cited by this paper
• Stages in the development of Parkinson’s disease-related pathology

  2004cited by this paper
• Mitochondrial transcription factor A regulates mtDNA copy number in mammals.

  2004cited by this paper
• 1‐Methyl‐4‐phenylpyridinium ion, a toxin that can cause parkinsonism, alters branched structures of DNA

  2002cited by this paper
• Release of replication termination controls mitochondrial DNA copy number after depletion with 2',3'-dideoxycytidine.

  2002cited by this paper
• Mechanism of mammalian mitochondrial DNA replication: import of mitochondrial transcription factor A into isolated mitochondria stimulates 7S DNA synthesis.

  2001cited by this paper
• The ratio of oxidative phosphorylation complexes I-V in bovine heart mitochondria and the composition of respiratory chain supercomplexes.

  2001cited by this paper
• Transcription and replication of mitochondrial DNA.

  2000cited by this paper
• The D-loop structure of human mtDNA is destabilized directly by 1-methyl-4-phenylpyridinium ion (MPP+), a parkinsonism-causing toxin.

  2000cited by this paper
• Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.

  1997cited by this paper
• Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson's disease

  1991cited by this paper
• Mitochondrial Complex I Deficiency in Parkinson's Disease

  1989influential reference
• Mitochondrial complex I deficiency in Parkinson's disease.

  1989cited by this paper
• Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

  1983cited by this paper

• Mechanisms of Cognitive Aging: Health and Pathology

  2026cites this paper
• Molecular markers and technique used for detection of liquid biopsy: Brief overview

  2025cites this paper
• Sex-specific microRNA regulators of Parkinson’s disease: insights from cohort-stratified simulations of compensatory pathway dynamics

  2025cites this paper
• Mitochondrial DNA signals driving immune responses: Why, How, Where?

  2025cites this paper
• Sex-specific mitochondrial DNA changes in neuron-derived extracellular vesicles of African American adults: impact of HIV infection and smoking

  2025cites this paper
• Untangling the Heart-Brain Connection in Parkinson's Disease: Emerging Mechanisms and Models.

  2025cites this paper
• Cerebellum mitochondrial DNA copy number is increased in Parkinson's disease.

  2025cites this paper
• Comparative Effects of Different Molecular Forms of Eicosapentaenoic Acid in Ameliorating 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson's Disease via Inhibition of Ferroptosis in C57BL/6 Mice

  2025cites this paper
• Mitochondrial DNA copy number and Alzheimer's disease and Parkinson disease.

  2025cites this paper
• The Protective Effect of Docosahexaenoic Acid on Mitochondria in SH-SY5Y Model of Rotenone-Induced Toxicity

  2025cites this paper
• Mitochondrial DNA Copy Number as a Potential Biomarker for the Severity of Motor Symptoms and Prognosis in Parkinson's Disease

  2025cites this paper
• Mitochondrial DNA (mtDNA) as fluid biomarker in neurodegenerative disorders: A systematic review

  2025cites this paper
• Evaluating Parkinson’s disease biomarkers in substantia nigra following sublethal γ-radiation exposure in a large animal model

  2025cites this paper
• CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiology

  2025cites this paper
• Released mitochondrial DNA and neurofilament light chain as Parkinson’s disease phenotypes in patient-specific midbrain assembloids

  2025cites this paper
• Association between mitochondrial DNA copy number and the risk of Parkinson’s disease: a meta-analysis and Mendelian randomization study

  2025cites this paper
• Dopaminergic Neuron‐Specific Tfam Knockout Links Inter‐Organelle Miscommunication to Early‐Onset Parkinsonism

  2025cites this paper
• Dopaminergic system and neurons: Role in multiple neurological diseases.

  2024cites this paper
• Single prolonged stress induces behavior and transcriptomic changes in the medial prefrontal cortex to increase susceptibility to anxiety-like behavior in rats

  2024cites this paper
• CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism

  2024cites this paper
• Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease

  2024cites this paper
• Age- and sex-associated alterations in hypothalamic mitochondrial bioenergetics and inflammatory-associated signaling in the 3xTg mouse model of Alzheimer’s disease

  2024cites this paper
• Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils

  2024cites this paper
• Mitochondrial Dysfunction: A Key Player in Brain Aging and Diseases

  2024cites this paper
• Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson’s disease

  2024cites this paper
• In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson’s disease

  2024influential citation
• Mitochondria transcription and cancer

  2024cites this paper
• Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond

  2024cites this paper
• Ergothioneine-Mediated Neuroprotection of Human iPSC-Derived Dopaminergic Neurons

  2024cites this paper
• Elevated serum circulating cell‐free mitochondrial DNA in amyotrophic lateral sclerosis

  2024cites this paper
• On the Chemical and Biological Characteristics of Multifunctional Compounds for the Treatment of Parkinson’s Disease

  2023cites this paper
• MitoQuicLy: a high-throughput method for quantifying cell-free DNA from human plasma, serum, and saliva

  2023cites this paper
• The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson’s Disease

  2023cites this paper
• ALTERED PROFILES OF EXTRACELLULAR MITOCHONDRIAL DNA IN IMMUNOPARALYZED PEDIATRIC PATIENTS AFTER THERMAL INJURY

  2023cites this paper
• Longitudinal Changes in Mitochondrial DNA Copy Number and Telomere Length in Patients with Parkinson’s Disease

  2023cites this paper
• SIRT3-Mediated Deacetylation of SDHA Rescues Mitochondrial Bioenergetics Contributing to Neuroprotection in Rotenone-Induced PD Models

  2023cites this paper
• Search for Molecular Biomarkers of Parkinson’s Disease. New Tissues and Methods

  2023cites this paper
• Integrated analysis of transcriptomic and proteomic alterations in mouse models of ALS/FTD identify early metabolic adaptions with similarities to mitochondrial dysfunction disorders

  2023cites this paper
• The multifaceted role of quercetin derived from its mitochondrial mechanism

  2023cites this paper
• Quantifying human genome parameters in aging

  2023cites this paper
• Targeting Mitochondrial Oxidative Stress: Potential Neuroprotective Therapy for Spinal Cord Injury.

  2023cites this paper
• Polygenic Risk Scores Validated in Patient‐Derived Cells Stratify for Mitochondrial Subtypes of Parkinson's Disease

  2023cites this paper
• JAC4 Alleviates Rotenone-Induced Parkinson’s Disease through the Inactivation of the NLRP3 Signal Pathway

  2023cites this paper
• Role of dopamine neuron activity in Parkinson's disease pathophysiology.

  2023cites this paper
• Plausible Role of Mitochondrial DNA Copy Number in Neurodegeneration—a Need for Therapeutic Approach in Parkinson’s Disease (PD)

  2023influential citation
• The Tricky Connection between Extracellular Vesicles and Mitochondria in Inflammatory-Related Diseases

  2023cites this paper
• POLG2-Linked Mitochondrial Disease: Functional Insights from New Mutation Carriers and Review of the Literature

  2023cites this paper
• The Impact of microRNAs on Mitochondrial Function and Immunity: Relevance to Parkinson’s Disease

  2023cites this paper
• Combating Dopaminergic Neurodegeneration in Parkinson's Disease through Nanovesicle Technology.

  2023cites this paper
• Disease mechanisms as Subtypes: Mitochondrial and bioenergetic dysfunction.

  2023cites this paper
• Parkinson’s Disease, Parkinsonisms, and Mitochondria: the Role of Nuclear and Mitochondrial DNA

  2023cites this paper
• Therapeutic considerations of bioactive compounds in Alzheimer's disease and Parkinson's disease: Dissecting the molecular pathways

  2023cites this paper
• Natural products targeting cellular processes common in Parkinson's disease and multiple sclerosis

  2023cites this paper
• APE1 regulates mitochondrial DNA damage repair after experimental subarachnoid haemorrhage in vivo and in vitro

  2023cites this paper
• Synaptic Involvement of the Human Amygdala in Parkinson’s Disease

  2023cites this paper
• A focus on natural products for preventing and cure of mitochondrial dysfunction in Parkinson’s disease

  2022cites this paper
• Neuroprotective effects of ATPase inhibitory factor 1 preventing mitochondrial dysfunction in Parkinson's disease

  2022cites this paper
• Mitochondrial DNA Homeostasis Impairment and Dopaminergic Dysfunction: A Trembling Balance.

  2022cites this paper
• Exercise-Boosted Mitochondrial Remodeling in Parkinson’s Disease

  2022cites this paper
• Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration

  2022cites this paper
• Redox Modulation of Mitochondrial Proteins in the Neurotoxicant Models of Parkinson's Disease

  2022cites this paper
• Radiotherapy Side Effects: Comprehensive Proteomic Study Unraveled Neural Stem Cell Degenerative Differentiation upon Ionizing Radiation

  2022cites this paper
• Comprehensive summary of mitochondrial DNA alterations in the postmortem human brain: A systematic review

  2022cites this paper
• Mitochondrial Respiratory Chain Dysfunction—A Hallmark Pathology of Idiopathic Parkinson’s Disease?

  2022cites this paper
• Targeting Mitochondria as a Therapeutic Approach for Parkinson’s Disease

  2022cites this paper
• mtDNA Maintenance and Alterations in the Pathogenesis of Neurodegenerative Diseases

  2022cites this paper
• Could Amyloid-β 1–42 or α-Synuclein Interact Directly with Mitochondrial DNA? A Hypothesis

  2022cites this paper
• Mitochondrial Calcium: Effects of Its Imbalance in Disease

  2022cites this paper
• Midbrain on Fire: mtDNA Ignites Neuroinflammation in PRKN‐P

  2022cites this paper
• Targeting Mitochondrial Function with Chemoptogenetics

  2022cites this paper
• Mitochondrial Damage-Associated Molecular Patterns Content in Extracellular Vesicles Promotes Early Inflammation in Neurodegenerative Disorders

  2022cites this paper
• Increased blood-derived mitochondrial DNA copy number in African ancestry individuals with Parkinson's disease.

  2022cites this paper
• Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy

  2022cites this paper
• Age-Associated Glia Remodeling and Mitochondrial Dysfunction in Neurodegeneration: Antioxidant Supplementation as a Possible Intervention

  2022cites this paper
• The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders

  2022cites this paper
• Modulation of cellular redox environment as a novel therapeutic strategy for Parkinson's disease

  2022cites this paper
• Growth Differentiation Factor 15 Protects SH-SY5Y Cells From Rotenone-Induced Toxicity by Suppressing Mitochondrial Apoptosis

  2022cites this paper
• TWNK in Parkinson's Disease: A Movement Disorder and Mitochondrial Disease Center Perspective Study

  2022cites this paper
• Potential anti‐Parkinsonian's effect of S‐(+)‐linalool from Cinnamomum osmophloeum ct. linalool leaves are associated with mitochondrial regulation via gas‐1, nuo‐1, and mev‐1 in Caenorhabditis elegans

  2022cites this paper
• Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson’s disease

  2022cites this paper
• Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease

  2022cites this paper
• Age-related mitochondrial dysfunction in Parkinson's disease: new insights into the disease pathology.

  2022cites this paper
• Parkin Deficiency Impairs Mitochondrial DNA Dynamics and Propagates Inflammation

  2022influential citation
• A genome on shaky ground: exploring the impact of mitochondrial DNA integrity on Parkinson’s disease by highlighting the use of cybrid models

  2022cites this paper
• Boosting mitochondrial health to counteract neurodegeneration.

  2022cites this paper
• HEK293T Cells with TFAM Disruption by CRISPR-Cas9 as a Model for Mitochondrial Regulation

  2021cites this paper
• Mitochondrial respiratory chain protein co-regulation in the human brain

  2021cites this paper
• Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases

  2021cites this paper
• Selective Neuron Vulnerability in Common and Rare Diseases—Mitochondria in the Focus

  2021cites this paper
• Evidence for the Role of Mitochondrial DNA Release in the Inflammatory Response in Neurological Disorders

  2021cites this paper
• Targeting Mitochondria and Redox Dyshomeostasis in Brain Ageing: An Update

  2021cites this paper
• IDO-1 inhibition protects against neuroinflammation, oxidative stress and mitochondrial dysfunction in 6-OHDA induced murine model of Parkinson's disease.

  2021cites this paper
• Mitochondrial homeostasis in cellular models of Parkinson's disease

  2021cites this paper
• Progressive parkinsonism due to mitochondrial impairment: Lessons from the MitoPark mouse model.

  2021cites this paper
• Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson’s disease? A critical reappraisal

  2021cites this paper
• Mice with disrupted mitochondria used to model Parkinson’s disease

  2021cites this paper
• Utilization of Laser Capture Microdissection Coupled to Mass Spectrometry to Uncover the Proteome of Cellular Protrusions.

  2021cites this paper
• Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling

  2021cites this paper
• Mitochondrial Oxidative Stress—A Causative Factor and Therapeutic Target in Many Diseases

  2021cites this paper
• Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s disease

  2021cites this paper